BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16144672)

  • 21. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
    Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique.
    Wah TM; Koenig P; Irving HC; Gervais DA; Mueller PR
    J Vasc Interv Radiol; 2005 Nov; 16(11):1551-5. PubMed ID: 16319166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
    Park BK; Kim CK
    Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Skipping' is still a problem with radiofrequency ablation of small renal tumours.
    Klingler HC; Marberger M; Mauermann J; Remzi M; Susani M
    BJU Int; 2007 May; 99(5):998-1001. PubMed ID: 17437433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Minimally invasive ablation techniques for small kidney tumors: cryoablation and radiofrequency].
    Caviezel A; Terraz S; Becker CD; Iselin C
    Rev Med Suisse; 2008 Dec; 4(182):2642-4, 2646-7. PubMed ID: 19160996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal infarction resulting from segmental arterial injury during radiofrequency ablation of renal tumor in patient with a single kidney.
    Park BK; Kim CK; Lim HK
    Urology; 2009 Feb; 73(2):442.e9-11. PubMed ID: 18597831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephron-sparing probe ablative therapy: long-term outcomes.
    Matin SF; Ahrar K
    Curr Opin Urol; 2008 Mar; 18(2):150-6. PubMed ID: 18303535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience.
    Liang P; Wang Y; Zhang D; Yu X; Gao Y; Ni X
    J Urol; 2008 Sep; 180(3):844-8; discussion 848. PubMed ID: 18635230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
    Watkins TW; Parkinson R
    Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
    Kunkle DA; Egleston BL; Uzzo RG
    J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation of renal tumors: past, present, and future.
    McAchran SE; Lesani OA; Resnick MI
    Urology; 2005 Nov; 66(5 Suppl):15-22. PubMed ID: 16194702
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites.
    Hirooka M; Kisaka Y; Uehara T; Ishida K; Kumagi T; Watanabe Y; Abe M; Matsuura B; Hiasa Y; Onji M
    Dig Endosc; 2009 Apr; 21(2):82-6. PubMed ID: 19691779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies: indication, limitation and results.
    Hildebrand P; Kleemann M; Roblick U; Mirow L; Birth M; Bruch HP
    Hepatogastroenterology; 2007; 54(79):2069-72. PubMed ID: 18251161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors.
    Bhayani SB; Allaf ME; Su LM; Solomon SB
    Urology; 2005 Mar; 65(3):592. PubMed ID: 15780392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates.
    Hui GC; Tuncali K; Tatli S; Morrison PR; Silverman SG
    J Vasc Interv Radiol; 2008 Sep; 19(9):1311-20. PubMed ID: 18725094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of radiofrequency ablation for treatment of localized renal carcinoma].
    Prokhorov DG; Shkol'nik MI; Shumskiĭ IA; Belov AD
    Vopr Onkol; 2008; 54(4):507-11. PubMed ID: 18942411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and laparoscopic partial nephrectomy for treating small renal tumours.
    Bensalah K; Zeltser I; Tuncel A; Cadeddu J; Lotan Y
    BJU Int; 2008 Feb; 101(4):467-71. PubMed ID: 17922853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.